Hetero Tenofovir/Lamivudine 300mg/300mg (30 Tablets)

Dual-Drug Antiretroviral Therapy Hetero Tenofovir/Lamivudine is a fixed-dose combination (FDC) tablet containing two potent antiretroviral agents: Tenofovir Disoproxil Fumarate (300mg) and Lamivudine (300mg). This combination belongs to the Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) class of medications. In Nigeria, it is commonly utilized as a "backbone" treatment for HIV-1 infection, typically combined with a third antiretroviral drug to form a complete regimen. It is also a primary choice for Post-Exposure Prophylaxis (PEP) and the management of Chronic Hepatitis B (HBV). Indications and Use

HIV-1 Treatment: Used as part of a combination regimen for adults and adolescents. Post-Exposure Prophylaxis (PEP): Often prescribed to prevent HIV infection after potential exposure (e.g., needle-stick injury or unprotected sexual contact). Chronic Hepatitis B: Effective in suppressing the Hepatitis B virus.

Dosage and Administration The standard dosage for adults is one tablet taken orally once daily, with or without food. It is important to take this medication at the same time every day to maintain consistent levels in the bloodstream. If you have questions about your regimen or missed a dose, you can chat with a Meddylab pharmacist for professional guidance. Important Safety Information While generally well-tolerated, some users may experience side effects such as nausea, dizziness, or fatigue. Long-term use requires monitoring of kidney function and bone density. Consult your healthcare provider before starting this medication to ensure it is appropriate for your clinical needs. Note: This medication is for managing chronic conditions and preventing infection; it is not a cure for HIV or Hepatitis B.

Product identification: Hetero Tenofovir/Lamivudine 300mg/300mg (30 Tablets) is listed under HIV. Use the exact product name when comparing alternatives or discussing an order with the supplier.